An audit found most of the biggest banks and largest community banks fail to meet basic Americans with Disabilities Act rules for website and app readability. U.S. Bank does more than most to make digital channels accessible.
The global corporate affairs department has axed or undermined more than 36 bills in 25 states that aim to regulate the amount of information the tech company can collect and store.
In recent years, Amazon.com Inc has killed or undermined privacy protections in more than three dozen bills across 25 states, as the e-commerce giant amassed a lucrative trove of personal data on millions of American consumers.
(0)
Global Industry leaders, thought leaders, Universities and government officials will speak during the 3-day openbusinesscouncil summit in partnership with WSCF World Smart Cities Forum and in collaboration with Ruh Global Impact on 20th, 21st and 22nd April 2021
LONDON, April 14, 2021 /PRNewswire/ openbusinesscouncil summit offers businesses and governments solutions to the urgency to create awareness for digital transformation, 4IR Tech to empower businesses and SMEs.
The
citiesabc and
World Smart Cities Forum, is running an online event with the aim to strengthen businesses, startups, and government s strategies post COVID-19.
The summit provides access to a unique audience and has indirect digital streaming in social media, that reaches over 10 million people.
1914
To leave the year with a bang, and to kick off 2021 as the year prioritizing patient safety and informed consent, I authored an open letter to the FDA appealing their denial of Freedom of Information Act (FOIA) request number 2020-7319.
The letter requested all electroconvulsive therapy (ECT) safety studies, pre-market approval (PMA) applications, and electric current limits (product development protocols or PDP) submitted by March 27, 2019.
Knowing my own ECT outcomes, and having researched similar outcomes for a decade, I feel ECT presents an “imminent threat to the life or physical safety” of gravely disabled individuals, warranting expedited release of data. The FDA denied it, however, writing that I had not “demonstrated a compelling need.”